Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
14,834,373
-
Shares change
-
-1,378,910
-
Total reported value, excl. options
-
$418,388,336
-
Value change
-
-$1,189,079
-
Number of sells
-
7
-
Price
-
$6.47
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2024
As of 30 Sep 2024 SINOVAC BIOTECH LTD. - Common Shares (SVA) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,834,373 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, ORBIMED ADVISORS LLC, Neumann Advisory Hong Kong Ltd, Horizon Investments, LLC, GROUP ONE TRADING LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, and WELLS FARGO & COMPANY/MN.
This table shows 11 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.